Adjuvant Chemotherapy Is Associated With Prolonged Survival Time in Small‐Breed Dogs Undergoing Amputation for Appendicular Osteosarcoma
Veterinary and Comparative Oncology · 2025
DOI: 10.1111/vco.13041 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veterinary and Comparative Oncology, 2025. Verfasst von Stefano Zanardi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Medical Sciences, University of Bologna, Ozzano dell'Emilia, Bologna, Italy. Hauptthemen laut MEDLINE: Osteosarcoma, Dog Diseases, Amputation, Surgical, Bone Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Adjuvant chemotherapy is a well‐established treatment for large‐breed dogs with appendicular osteosarcoma; however, it is unclear if it improves outcomes in small‐breed dogs due to limited focused studies. This retrospective study aimed to investigate the oncologic outcomes of dogs weighting less than 15 kg with appendicular osteosarcoma that underwent curative resection with or without postoperative adjuvant chemotherapy. Endpoints were time to distant progression (TTDP) and overall survival (OS). Medical records from multiple institutions were reviewed, and 43 dogs were included in the analysis: 17 underwent surgery alone and 26 also received adjuvant chemotherapy. The median TTDP for all dogs was 265 days, with no significant difference between treatment groups. The median OS for all dogs was 270 days, and it was significantly different between amputated dogs (150 days) and those also receiving adjuvant chemotherapy (353 days, p = 0.002). In our cohort, osteosarcoma in small breeds behaved as aggressive as in large breeds. Adjuvant chemotherapy may prolong survival. Future randomised studies are needed to provide definitive evidence on the necessity of adjuvant chemotherapy to address metastatic spread in small‐breed dogs with appendicular osteosarcoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Veterinary Medical Sciences, University of Bologna, Ozzano dell'Emilia, Bologna, Italy.
- Anicura Clinica Veterinaria dell'Orologio, Bologna, Italy.
- Department of Clinical Science and Services, The Royal Veterinary College, Hatfield, UK.
- Department of Veterinary Science, University of Turin, Turin, Italy.
- Anicura Clinica Veterinaria Malpensa, Varese, Italy.
- Pronto Soccorso Veterinario Laudense, Lodi, Italy.
ORCID-Profile: Silvia Sabattini, Laura Marconato
Zitieren
APA
Zanardi, S., Sabattini, S., Rossi, F., Rossanese, M., Buracco, P., Montinaro, V., Aralla, M., Dentini, A., Pizzi, E., Volpe, E., Tremolada, G., & Marconato, L. (2025). Adjuvant Chemotherapy Is Associated With Prolonged Survival Time in Small‐Breed Dogs Undergoing Amputation for Appendicular Osteosarcoma. Veterinary and Comparative Oncology. https://doi.org/10.1111/vco.13041
Vancouver
Zanardi S, Sabattini S, Rossi F, Rossanese M, Buracco P, Montinaro V, et al. Adjuvant Chemotherapy Is Associated With Prolonged Survival Time in Small‐Breed Dogs Undergoing Amputation for Appendicular Osteosarcoma. Veterinary and Comparative Oncology. 2025. doi:10.1111/vco.13041
BibTeX
@article{Zanardi2025,
author = {Zanardi, Stefano and Sabattini, Silvia and Rossi, Federica and Rossanese, Matteo and Buracco, Paolo and Montinaro, Vincenzo and Aralla, Marina and Dentini, Alfredo and Pizzi, Elisa and Volpe, Enrico and Tremolada, Giovanni and Marconato, Laura},
title = {Adjuvant Chemotherapy Is Associated With Prolonged Survival Time in Small‐Breed Dogs Undergoing Amputation for Appendicular Osteosarcoma},
journal = {Veterinary and Comparative Oncology},
year = {2025},
doi = {10.1111/vco.13041}
}
EUVIMED